Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Feb 25, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Market Capitalization	628	216	113	35	44	113
Market Cap Growth	172.31%	91.16%	221.19%	-19.99%	-61.12%	200.36%
Enterprise Value	460	-48	98	-19	-14	49
Last Close Price	5.42	3.19	4.02	2.47	3.09	7.98
PS Ratio	587.05	148.28	78.65	6.49	-	11.23
PB Ratio	1.66	0.74	1.50	0.64	0.72	1.68
P/TBV Ratio	3.28	0.90	147.82	0.64	0.72	1.68
EV/Sales Ratio	428.15	-	68.42	-	-	4.86
Debt / Equity Ratio	0.01	0.01	0.03	-	0.01	0.01
Net Debt / Equity Ratio	-0.70	-0.77	-0.09	-0.80	-0.90	-0.93
Net Debt / EBITDA Ratio	1.86	3.46	0.17	5.16	9.02	19.54
Net Debt / FCF Ratio	1.60	3.07	0.18	4.10	6.94	19.59
Asset Turnover	0.00	0.01	0.02	-	-	0.25
Inventory Turnover	-	-	-	-	-	6.07
Quick Ratio	8.46	12.53	0.67	14.47	25.38	36.58
Current Ratio	8.66	12.68	1.08	17.07	26.18	37.37
Return on Equity (ROE)	-37.26%	-42.82%	-57.70%	-	-9.79%	-9.26%
Return on Assets (ROA)	-17.24%	-19.02%	-32.81%	-	-5.95%	-5.43%
Return on Capital Employed (ROCE)	-34.50%	-20.70%	-49.80%	-16.00%	-10.30%	-5.00%
Earnings Yield	-16.76%	-36.77%	-41.23%	-30.64%	-16.57%	-3.00%
FCF Yield	-16.91%	-33.72%	-33.68%	-30.42%	-18.17%	-2.85%
Buyback Yield / Dilution	-35.71%	-140.72%	-88.38%	-0.06%	-36.73%	-53.61%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q